Lawsuit Intelligencer Vol. I · No. 5 · September 2026

Lawsuit Intelligencer

Editorial analysis of mass torts, product liability, toxic exposure litigation, and the business of plaintiff-side law in the age of AI.

Lawsuit Intelligencer covers the lawsuits, regulations, referral systems, legal marketing practices, and technologies reshaping modern litigation — the questions that don't fit in consumer legal media or law firm marketing.

Recent

  1. The Preparation Does Much of the Negotiating

    Elliott Portnoy, who now advises private equity sponsors on law firm MSO transactions, on why the plaintiff-side deals that close at higher multiples were mostly won a year before the first sponsor meeting.

    By David Meldofsky · 5 min read

  2. Cross-Examined by Your Own Chat Log

    Two federal courts divided in February over whether a party’s AI conversations are discoverable. Both were arguing about chats the party made for the case. In a mass tort the dangerous material sits years earlier, in a timestamped conversation the plaintiff has forgotten writing.

    By David Meldofsky · 11 min read

  3. Courts Are Writing the AI Rules. They Won’t Let AI in the Room.

    A prospective juror researched a pending Georgia murder case and told the rest of the pool what he found. Both sides moved jointly for a mistrial, and a second judge later put the cost of the discharged panel at $4,762.43. The same courts now deciding what AI companies owe the public forbid the technology in their own deliberations.

    By David Meldofsky · 8 min read

  4. Arizona v. L'Oréal Moves the Hair Relaxer Fight to Disclosure

    Arizona sued L'Oréal under a consumer fraud statute that needs no injured consumer. The case sits in Maricopa County while 11,779 federal cases wait on a causation ruling, and it asks what the company told buyers.

    By David Meldofsky · 7 min read

  5. State AI Enforcement Tracker

    Every state consumer-harm action against a generative AI company, read from the filings rather than the press releases. Florida is now pleading strict liability design defect against a large language model. Pennsylvania's licensing board needed no injured party at all.

    By David Meldofsky · Updated September 2026

  6. The Expert Has to Be Right the Same Way, Forty Times

    Josh Hyatt of Expert Institute on why a prior transcript sinks more experts than a thin CV does, and what a bellwether program demands of a witness that a single case never will.

    By David Meldofsky · 6 min read

  7. What Plaintiff Firms Get Wrong When They Buy Claimant Acquisition

    Brian Beck of Typhon Interactive puts numbers on the difference between a firm that works its leads and one that doesn’t, and explains why mass arbitration is a technology problem before it is a media problem.

    By David Meldofsky · 7 min read

  8. The ChatGPT Log You Can’t Subpoena: Preserving Chat Evidence in AI Injury Litigation

    The Stored Communications Act blocks the third-party subpoena most practitioners reach for, and the order that suspended routine deletion terminated in September 2025. In the AI injury docket, the evidence case is won or lost in the first week of intake.

    By David Meldofsky · 14 min read

  9. The AI Tort That Skips the Output Question

    Judge Lee held that Otter.ai is a third-party eavesdropper under CIPA not because the notetaker was uninvited, but because it trains on what it records. The theory reaches an AI company's balance sheet without anyone having to answer the product-or-content question first.

    By David Meldofsky · 8 min read

  10. MDL 3026 Finally Has a Jury in the NEC Docket

    Three federal bellwethers never reached a jury. The fourth is being tried in Chicago now, and what it actually tests is not the epidemiology but whether a better warning would have changed how one NICU fed one infant.

    By David Meldofsky · 7 min read

  11. The Handwritten Line in the ChatGPT Leadership Order

    CMO No. 1 in the coordinated ChatGPT product liability cases appoints the usual leadership and bars everyone else from filing on liability. Then the judge added a line by hand preserving a self-represented plaintiff's right to be heard. The mechanics are worth reading closely.

    By David Meldofsky · 8 min read

  12. The Case You Can’t Serve

    A Senate bill would create a contingent-fee action against the President, his family, and federal contractors. Then it names an intervenor that does not exist.

    By David Meldofsky · 5 min read

  13. The Docket the Panel Wouldn't Build

    Twice denied an MDL, the video game addiction litigation re-formed around a California coordination, scattered federal filings, and, since March, school districts. For plaintiff firms, the structure is now the story.

    By David Meldofsky · 5 min read

  14. ByHeart's Five-Month Sprint to MDL 3178

    A November recall became a centralized federal docket by April — one of the fastest recall-to-MDL runs in recent memory. The hybrid structure, the single-defendant economics, and the first outbreak of its kind make this a different underwriting problem than the latency torts.

    By David Meldofsky · 6 min read

  15. AI Due-Diligence Queries Are Reading Your Firm

    Search Console data across an attorney-run legal publishing network keeps surfacing the same thing: templated, machine-built queries scanning companies for litigation exposure and scanning legal brands for legitimacy. The assistants are checking references before they cite. Most firms have no page that answers.

    By David Meldofsky · 5 min read

  16. Hair Relaxer's Daubert Gate and Intake Economics

    Eleven and a half thousand cases are waiting on one admissibility ruling. The general-causation Daubert fight in MDL 3060 is the binary event that reprices every hair relaxer inventory in the country — and the Acetaminophen MDL is the cautionary tale everyone in the room remembers.

    By David Meldofsky · 6 min read

  17. The Startup Suing Washington Over an AI Kill Switch

    A San Jose legal-tech startup is suing the federal government to reverse the export-control order that switched off Anthropic's Fable 5 and Mythos 5. A plain-language guide to the claims, the government's likely defenses, and the first real test of whether Washington can disable a frontier AI model already in use.

    By David Meldofsky · 8 min read

  18. The Conduit Defense Meets a Sovereign: Fable 5, Garcia, and Section 230

    An export-control directive pulled Claude Fable 5 offline as a controlled capability, not protected speech. What the takedown, the Garcia product ruling, and Anthropic's own call for FAA-style regulation mean for the product-or-content question and the Section 230 defense.

    By David Meldofsky · 9 min read

  19. The Inventory Nobody Knows How to Price: Inside the AI Wrongful Death Docket

    Four case fronts in ten months, all pretrial, and a filing pace that keeps accelerating. How plaintiff firms are building inventory against a docket with no settlement history, no merits ruling, and no consolidation — and what reprices it in the second half of 2026.

    By David Meldofsky · 10 min read

  20. The First AI Infrastructure Class Action: 10,000 Mississippi Residents Take On xAI's Colossus Gas Plant

    A nuisance suit filed this week opens a second litigation front against the same Southaven facility already facing a Clean Air Act citizen suit, a pending preliminary injunction, and possible DOJ intervention. The physical-externalities half of the AI docket has arrived.

    By David Meldofsky · 7 min read

  21. The Fee That Isn’t a Fee

    Private equity’s path into personal injury law rests on a single undefined word. California and Illinois wrote it into their statutes without saying what it means — and no court has decided where a management fee ends and “indirect” fee-sharing begins.

    By David Meldofsky · 7 min read

  22. Federal PFAS Rules Are Contracting. State PFAS Rules Aren't. The Litigation Will Follow the States.

    The 2024 EPA drinking water standards looked like a foundation for the next wave of PFAS litigation. EPA's 2025–2026 rollback collapsed that assumption. What changes for plaintiff lawyers when the federal anchor moves and the state floors don't.

    By David Meldofsky · 8 min read

  23. AI Can Write the Brief. You Still Have to Verify It.

    The sanctions docket is now its own body of law, and almost every entry failed at the same step. A working guide to using generative AI in court filings without ending up in a show-cause order.

    By David Meldofsky · 9 min read

  24. Mass Tort Intake Is About to Get Reshaped — Not by the FCC, but by Plaintiffs' Lawyers

    The Eleventh Circuit's 2025 vacatur of the one-to-one consent rule is being misread as a regulatory all-clear. The actual pressure has just shifted to TCPA class actions and state bar enforcement.

    By David Meldofsky · 10 min read

  25. Welcome to Lawsuit Intelligencer

    What this publication is, what it isn't, and why it exists.

    By David Meldofsky · 3 min read

Interviews

From the Editor, Published Elsewhere

What We Cover

Mass Torts & Product Liability

PFAS, AFFF, talc, pharmaceutical and medical device litigation, MDL practice, and the doctrines moving through them.

The Business of Plaintiff-Side Law

Intake, referral economics, lead generation, legal marketing, AI in legal practice, firm consolidation, and the regulatory environment around all of it.

Regulation That Moves Litigation

Federal and state agency action — EPA, FDA, FCC, state AGs, state bars — analyzed for what it means in court, not what the press release said.